FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3146778807> ?p ?o ?g. }

• W3146778807 endingPage "999" @default.
• W3146778807 startingPage "993" @default.
• W3146778807 abstract "Purpose Dose escalation for prostate cancer can be achieved with a combination of external beam radiotherapy (EBRT) and brachytherapy (BT) boost to increase local control. For high-dose-rate (HDR)-BT, optimal fractionation remains under debate. The objective was to assess the clinical outcome of three schemes of HDR-BT boost. Methods and Materials Retrospective single institution data collection was performed. Patients received 46 Gy EBRT then an HDR-BT boost: 3 × 6 Gy, 2 × 9 Gy, or 1 × 14 Gy. HDR needles were placed under general anesthesia with endorectal ultrasonography guidance. CT-scan and treatment were performed postoperatively. Results Between 2009 and 2012, 159 patients were included. Nine patients (5.7%) were low, 32 (20.1%) intermediate, and 118 (74.2%) high risk (D'Amico classification) without significant difference between the three BT schemes. With a median followup of 61 months, 5-year biochemical relapse–free survival, 5-year local relapse–free survival, 5-year metastases-free survival, and 5-year overall survival rates were 86.6% (SE 2.7%), 98.3% (SE 1%), 95.3% (SE 1%), and 96.5% (SE 1.5%), respectively, with no significant difference between the BT schemes. The rates of acute ≥ G2 genitourinary and ≥G2 gastrointestinal toxicities were 11.3% and 6.3%, respectively (p = NS). The rates of late genitourinary ≥ G2 and gastrointestinal ≥ G2 toxicities (at last followup) were 9.4% and 0.6% with, respectively, 0.6% and 0% of G4 (p = NS). Conclusions Hypofractionation up to a single-fraction HDR-BT boost for prostate cancer yields similar results in terms of biochemical control and late toxicity compared with two or three-fraction schemes. Single fraction HDR-BT appears acceptable for boosting prostate cancer after definitive EBRT." @default.
• W3146778807 created "2021-04-13" @default.
• W3146778807 creator A5005749193 @default.
• W3146778807 creator A5021680018 @default.
• W3146778807 creator A5023675047 @default.
• W3146778807 creator A5025647486 @default.
• W3146778807 creator A5031202796 @default.
• W3146778807 creator A5041049746 @default.
• W3146778807 creator A5042890358 @default.
• W3146778807 creator A5051045216 @default.
• W3146778807 creator A5070991360 @default.
• W3146778807 creator A5083431096 @default.
• W3146778807 date "2017-09-01" @default.
• W3146778807 modified "2023-09-27" @default.
• W3146778807 title "High-dose-rate brachytherapy boost for prostate cancer: Comparison of three different fractionation schemes" @default.
• W3146778807 cites W1964041265 @default.
• W3146778807 cites W2004529478 @default.
• W3146778807 cites W2047912614 @default.
• W3146778807 cites W2048239925 @default.
• W3146778807 cites W2049677718 @default.
• W3146778807 cites W2056064074 @default.
• W3146778807 cites W2062313368 @default.
• W3146778807 cites W2086604707 @default.
• W3146778807 cites W2105211307 @default.
• W3146778807 cites W2107212845 @default.
• W3146778807 cites W2130514725 @default.
• W3146778807 cites W2141944007 @default.
• W3146778807 cites W2163954169 @default.
• W3146778807 cites W2174187309 @default.
• W3146778807 cites W2286889160 @default.
• W3146778807 cites W2429858131 @default.
• W3146778807 cites W2528108834 @default.
• W3146778807 cites W2534892684 @default.
• W3146778807 cites W2553678345 @default.
• W3146778807 cites W2588352921 @default.
• W3146778807 cites W2602775013 @default.
• W3146778807 doi "https://doi.org/10.1016/j.brachy.2017.06.013" @default.
• W3146778807 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28754301" @default.
• W3146778807 hasPublicationYear "2017" @default.
• W3146778807 type Work @default.
• W3146778807 sameAs 3146778807 @default.
• W3146778807 citedByCount "18" @default.
• W3146778807 countsByYear W31467788072017 @default.
• W3146778807 countsByYear W31467788072018 @default.
• W3146778807 countsByYear W31467788072019 @default.
• W3146778807 countsByYear W31467788072020 @default.
• W3146778807 countsByYear W31467788072021 @default.
• W3146778807 countsByYear W31467788072022 @default.
• W3146778807 countsByYear W31467788072023 @default.
• W3146778807 crossrefType "journal-article" @default.
• W3146778807 hasAuthorship W3146778807A5005749193 @default.
• W3146778807 hasAuthorship W3146778807A5021680018 @default.
• W3146778807 hasAuthorship W3146778807A5023675047 @default.
• W3146778807 hasAuthorship W3146778807A5025647486 @default.
• W3146778807 hasAuthorship W3146778807A5031202796 @default.
• W3146778807 hasAuthorship W3146778807A5041049746 @default.
• W3146778807 hasAuthorship W3146778807A5042890358 @default.
• W3146778807 hasAuthorship W3146778807A5051045216 @default.
• W3146778807 hasAuthorship W3146778807A5070991360 @default.
• W3146778807 hasAuthorship W3146778807A5083431096 @default.
• W3146778807 hasConcept C121608353 @default.
• W3146778807 hasConcept C126322002 @default.
• W3146778807 hasConcept C126838900 @default.
• W3146778807 hasConcept C126894567 @default.
• W3146778807 hasConcept C133507102 @default.
• W3146778807 hasConcept C141071460 @default.
• W3146778807 hasConcept C155806632 @default.
• W3146778807 hasConcept C167135981 @default.
• W3146778807 hasConcept C2775908122 @default.
• W3146778807 hasConcept C2776235491 @default.
• W3146778807 hasConcept C2777416452 @default.
• W3146778807 hasConcept C2780192828 @default.
• W3146778807 hasConcept C2989005 @default.
• W3146778807 hasConcept C509974204 @default.
• W3146778807 hasConcept C71924100 @default.
• W3146778807 hasConceptScore W3146778807C121608353 @default.
• W3146778807 hasConceptScore W3146778807C126322002 @default.
• W3146778807 hasConceptScore W3146778807C126838900 @default.
• W3146778807 hasConceptScore W3146778807C126894567 @default.
• W3146778807 hasConceptScore W3146778807C133507102 @default.
• W3146778807 hasConceptScore W3146778807C141071460 @default.
• W3146778807 hasConceptScore W3146778807C155806632 @default.
• W3146778807 hasConceptScore W3146778807C167135981 @default.
• W3146778807 hasConceptScore W3146778807C2775908122 @default.
• W3146778807 hasConceptScore W3146778807C2776235491 @default.
• W3146778807 hasConceptScore W3146778807C2777416452 @default.
• W3146778807 hasConceptScore W3146778807C2780192828 @default.
• W3146778807 hasConceptScore W3146778807C2989005 @default.
• W3146778807 hasConceptScore W3146778807C509974204 @default.
• W3146778807 hasConceptScore W3146778807C71924100 @default.
• W3146778807 hasIssue "5" @default.
• W3146778807 hasLocation W31467788071 @default.
• W3146778807 hasLocation W31467788072 @default.
• W3146778807 hasLocation W31467788073 @default.
• W3146778807 hasOpenAccess W3146778807 @default.
• W3146778807 hasPrimaryLocation W31467788071 @default.
• W3146778807 hasRelatedWork W2028851625 @default.
• W3146778807 hasRelatedWork W2085066133 @default.

• next